Javascript must be enabled to continue!
Copper-mediated regulation of CK2 kinase activity
View through CrossRef
The evolutionarily conserved serine/threonine kinase CK2 has hundreds of known substrates and plays an essential role in a number of signaling pathways that regulate cell growth and proliferation. Perturbances in these pathways are often associated with tumorigenesis, and indeed, overexpression of CK2 is associated with several cancer types and decreased patient survival. Compared to other protein kinases, CK2 displays several unusual properties, one being constitutive activity. Despite this apparent lack of regulation, it is hypothesized that some mode of regulation likely exists which is, as of yet, uncharacterized. In this study, we provide evidence that CK2 binds the transitional metal copper and that this binding is crucial for its kinase activity. Specific residues in the catalytic subunit of CK2 involved in copper-binding were identified and subsequently mutated. We demonstrate that this CK2 mutant has a decreased ability to phosphorylate substrate proteins in a glioblastoma cell line and in an in-vitro kinase assay. Overall, we provide preliminary data suggesting that CK2 kinase activity is regulated by its ability to bind copper. These results shed light on a novel mechanism controlling CK2 activity that may be important for targeting in cancers driven by CK2 kinase signaling.
Title: Copper-mediated regulation of CK2 kinase activity
Description:
The evolutionarily conserved serine/threonine kinase CK2 has hundreds of known substrates and plays an essential role in a number of signaling pathways that regulate cell growth and proliferation.
Perturbances in these pathways are often associated with tumorigenesis, and indeed, overexpression of CK2 is associated with several cancer types and decreased patient survival.
Compared to other protein kinases, CK2 displays several unusual properties, one being constitutive activity.
Despite this apparent lack of regulation, it is hypothesized that some mode of regulation likely exists which is, as of yet, uncharacterized.
In this study, we provide evidence that CK2 binds the transitional metal copper and that this binding is crucial for its kinase activity.
Specific residues in the catalytic subunit of CK2 involved in copper-binding were identified and subsequently mutated.
We demonstrate that this CK2 mutant has a decreased ability to phosphorylate substrate proteins in a glioblastoma cell line and in an in-vitro kinase assay.
Overall, we provide preliminary data suggesting that CK2 kinase activity is regulated by its ability to bind copper.
These results shed light on a novel mechanism controlling CK2 activity that may be important for targeting in cancers driven by CK2 kinase signaling.
Related Results
Activation of protein kinase CK2 by LPS is mediated by the MAP kinase pathway
Activation of protein kinase CK2 by LPS is mediated by the MAP kinase pathway
Stimulation of macrophages by Gram-negative bacterial lipopolysaccharide (LPS) rapidly leads to the activation of several protein kinases and the subsequent phosphorylation of tran...
Regulation of Human Sickle Erythrocyte Hydration Status by Endothelin-1 Is Mediated by Casein Kinase II.
Regulation of Human Sickle Erythrocyte Hydration Status by Endothelin-1 Is Mediated by Casein Kinase II.
Abstract
Abstract 3020
Poster Board II-996
In Sickle Cell Disease, K+ efflux and osmotically induced water loss leads to erythrocyte de...
On Casein Kinase-2 (CK2) deregulation in NSCLC: an enzyme subunit-centered approach
On Casein Kinase-2 (CK2) deregulation in NSCLC: an enzyme subunit-centered approach
Abstract
CK2 is considered a constitutively active protein kinase promoting/supporting several neoplastic properties and inducing a so-called non-oncogene addiction...
Abstract 2527: Regulation of mitotic progression in T-cell acute lymphoblastic leukemia by the Ikaros tumor suppressor
Abstract 2527: Regulation of mitotic progression in T-cell acute lymphoblastic leukemia by the Ikaros tumor suppressor
Abstract
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy that represents a therapeutic challenge. Next-generation sequencing re...
Conception, synthèse et évaluation d’inhibiteurs de la protéine-kinase CK2
Conception, synthèse et évaluation d’inhibiteurs de la protéine-kinase CK2
CK2 (CSNK2) est une sérine/thréonine-kinase constitutivement active, ubiquitaire, qui contribue à près de 20% du phosphoproteome. Présente sous forme d’un monomère CK2α et égalemen...
Transcriptional Regulation of Cell Cycle Progression in T‐Cell Leukemia
Transcriptional Regulation of Cell Cycle Progression in T‐Cell Leukemia
The
IKZF1
gene encodes the Ikaros protein that acts as a tumor suppressor in acute lymphoblastic leukemia (ALL). The role of Ikaros in T‐cel...
Abstract 5540: Transcriptional control of signaling pathways in T-cell lymphoblastic leukemia by Ikaros tumor suppressor
Abstract 5540: Transcriptional control of signaling pathways in T-cell lymphoblastic leukemia by Ikaros tumor suppressor
Abstract
Cellular proliferation in T-cell acute lymphoblastic leukemia is regulated by multiple signaling pathways. The Phosphoinositide 3-kinase (PI3K)/AKT pathway ...
Regulation of the epigenetic signature in leukemia by Ikaros (800.5)
Regulation of the epigenetic signature in leukemia by Ikaros (800.5)
Ikaros encodes a DNA binding protein that regulates gene expression via chromatin remodeling and epigenetic mechanisms. The loss of Ikaros activity due to genetic or functional ina...

